SpaceX: Why You Should Consider Buying After The IPO Bubble Implodes

The article places SpaceX on a speculative buy list, citing the view that AI could drive >90% of its business by 2030 and revenue potentially reaching ~$365B. However, it highlights extreme execution risk and wide valuation dispersion ($62 to $800) alongside expected near-term volatility tied to insider share unlocks through 2027. Overall, the setup is high-upside but highly uncertain, likely to influence sentiment more than fundamentals in the near term.

Analysis

This is less a fundamentals story than a sequencing problem: the market will likely pay for optionality only if there is evidence that AI is becoming a repeatable revenue engine rather than an internal efficiency layer. The risk is that the business mix shifts toward a software-style multiple before the cash flows justify it, which tends to create valuation air pockets in late-stage private names when growth is still mostly narrative.

The more immediate tradable variable is the supply overhang from insider unlocks. In private markets, that usually matters before the actual unlock date because employees and early holders start hedging through secondary sales, widening discounts and compressing implied valuation even if operating momentum is intact. That makes the next 12-24 months more about clearing supply than about the 2030 TAM slide.

Contrarian view: consensus may be underestimating how hard it is for a capital-intensive, project-based platform to turn AI into durable, high-margin recurring revenue. If the AI layer is mostly an enablement function, the upside accrues to compute and infrastructure vendors, while the company itself remains valued on lumpy cash flows. The cleaner public-market expression of the thesis may be upstream beneficiaries, not the private equity story itself.

Key Decisions for Investors

• No direct public-equity trade in SPCX at current information quality; treat this as an optionality asset and wait for third-party evidence of monetized AI bookings before paying up.
• If expressing the thesis publicly, favor a small long NVDA / short high-beta private-AI sentiment basket via ARKK on rallies over the next 1-3 months; the monetization path is more likely to accrue to compute suppliers than to the issuer itself.
• Avoid chasing listed space-beta names like RKLB on the assumption of a SpaceX AI re-rating; if anything, use RKLB as a tactical short only if evidence emerges that SpaceX is using AI to widen launch-cost/cadence advantage over the next 6-12 months.
• Set a watch alert for secondary-market discounts around the 2026-2027 unlock window; if implied private valuation starts clearing down by 15-20% without corresponding revenue confirmation, that is the point to fade the story, not front-run it.
• Falsifier: any disclosed AI revenue run-rate or backlog that is large enough to move the company toward a recurring-revenue mix by 2027 would invalidate the 'narrative only' view and justify re-underwriting the name.